Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review

Código QR

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review

Jinghong Liang, Jiayu Li, Ruixia Jia, Yingquan Wang, Rongkun Wu, Hongbo Zhang, Lei Hang, Yong Xu Department of Child Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Soochow University, Suzhou, China Purpose: The increasing pr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liang JH, Li JY, Jia RX, Wang YQ, Wu RK, Zhang HB, Hang L, Xu Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Alzheimer’s disease cognitive drugs Bayesian network meta-analysis Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/7f2e7222cdfa4ae0adcca28964972a0e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
por: Chen J, et al.
Publicado: (2019)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
por: Cheng D, et al.
Publicado: (2014)

Physical activity can improve cognition in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
por: Du Z, et al.
Publicado: (2018)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin EY, et al.
Publicado: (2020)

Occupational activity and cognitive reserve: implications in terms of prevention of cognitive aging and Alzheimer’s disease
por: Adam S, et al.
Publicado: (2013)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
por: Onofri E, et al.
Publicado: (2015)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

Effectiveness of weekly cognitive stimulation therapy for people with dementia and the additional impact of enhancing cognitive stimulation therapy with a carer training program
por: Cove J, et al.
Publicado: (2014)

Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis
por: Jiang Y, et al.
Publicado: (2017)

Legal medical consideration of Alzheimer’s disease patients’ dysgraphia and cognitive dysfunction a 6 month follow up
por: Onofri E, et al.
Publicado: (2016)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
por: Mao CJ, et al.
Publicado: (2017)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013)

Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Yuda N, et al.
Publicado: (2020)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial
por: Zhao J, et al.
Publicado: (2018)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Mild cognitive impairment and its management in older people
por: Eshkoor SA, et al.
Publicado: (2015)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai MC, et al.
Publicado: (2015)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
por: Ohnuma T, et al.
Publicado: (2016)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

Lower cognitive function in patients with age-related macular degeneration: a meta-analysis
por: Zhou LX, et al.
Publicado: (2016)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience
por: Ding B, et al.
Publicado: (2014)